MONTI, GIACOMO
 Distribuzione geografica
Continente #
EU - Europa 3.600
AS - Asia 2.908
NA - Nord America 2.893
SA - Sud America 473
AF - Africa 72
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 3
Totale 9.965
Nazione #
US - Stati Uniti d'America 2.785
RU - Federazione Russa 1.991
SG - Singapore 1.068
CN - Cina 842
IT - Italia 525
HK - Hong Kong 384
BR - Brasile 371
VN - Vietnam 255
SE - Svezia 236
DE - Germania 223
FR - Francia 150
GB - Regno Unito 113
IN - India 82
FI - Finlandia 72
CA - Canada 63
NL - Olanda 58
PL - Polonia 50
TR - Turchia 39
AT - Austria 35
ZA - Sudafrica 34
JP - Giappone 33
MX - Messico 32
BD - Bangladesh 31
ES - Italia 29
AR - Argentina 26
ID - Indonesia 26
IE - Irlanda 24
PK - Pakistan 21
IQ - Iraq 20
CO - Colombia 17
PH - Filippine 16
AU - Australia 14
UA - Ucraina 14
CZ - Repubblica Ceca 13
UZ - Uzbekistan 13
PE - Perù 12
LT - Lituania 11
MY - Malesia 11
CL - Cile 10
VE - Venezuela 10
AE - Emirati Arabi Uniti 9
BE - Belgio 9
EG - Egitto 9
HU - Ungheria 9
PY - Paraguay 9
SA - Arabia Saudita 9
TH - Thailandia 9
CH - Svizzera 8
EC - Ecuador 8
MA - Marocco 8
TN - Tunisia 8
IR - Iran 7
NO - Norvegia 7
BO - Bolivia 5
LU - Lussemburgo 5
TW - Taiwan 5
UY - Uruguay 5
IL - Israele 4
OM - Oman 4
CR - Costa Rica 3
DK - Danimarca 3
ET - Etiopia 3
GR - Grecia 3
KZ - Kazakistan 3
LV - Lettonia 3
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EU - Europa 2
JM - Giamaica 2
KE - Kenya 2
KR - Corea 2
KW - Kuwait 2
MG - Madagascar 2
NP - Nepal 2
PT - Portogallo 2
RS - Serbia 2
BG - Bulgaria 1
BN - Brunei Darussalam 1
EE - Estonia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
KH - Cambogia 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
MN - Mongolia 1
MV - Maldive 1
NG - Nigeria 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
SN - Senegal 1
SY - Repubblica araba siriana 1
Totale 9.961
Città #
Dallas 924
Singapore 584
Hong Kong 374
Ashburn 373
Moscow 360
San Jose 220
Shanghai 169
Beijing 164
New York 155
Milan 151
Hefei 108
Lauterbourg 91
Ho Chi Minh City 89
Munich 82
Boardman 72
Los Angeles 67
Council Bluffs 62
Lawrence 61
Princeton 61
Hanoi 53
São Paulo 48
Nuremberg 39
Warsaw 37
Helsinki 36
Orem 34
Denver 33
Tokyo 31
Santa Clara 28
Guangzhou 27
Poplar 27
Brooklyn 26
London 26
Chennai 25
Dublin 24
Johannesburg 24
Turku 22
Frankfurt am Main 21
Seattle 21
Rome 20
Turin 20
Amsterdam 19
Rio de Janeiro 19
Atlanta 18
Manchester 18
Ankara 17
Boston 17
Montreal 17
Stockholm 17
Mexico City 16
Toronto 15
Jakarta 14
Vienna 14
Falkenstein 13
Washington 13
Barnet 12
Phoenix 12
Cesano Boscone 11
Tashkent 11
The Dalles 11
Chicago 10
Da Nang 10
Istanbul 10
Lappeenranta 10
Madrid 10
New Delhi 10
St Petersburg 10
Belo Horizonte 9
Biên Hòa 9
Haiphong 9
Houston 9
Naples 9
Paris 9
Baghdad 8
Bari 8
Hải Dương 8
Prague 8
San Francisco 8
Zhengzhou 8
Columbus 7
Hangzhou 7
Kassel 7
Lima 7
Mumbai 7
Rho 7
Tianjin 7
Brasília 6
Budapest 6
Calgary 6
Charlotte 6
Gatchina 6
Geleen 6
Pune 6
Querétaro 6
Shenzhen 6
Thái Bình 6
Brescia 5
Buenos Aires 5
Campinas 5
Kuala Lumpur 5
Lahore 5
Totale 5.379
Nome #
Pirfenidone to prevent fibrosis in acute respiratory distress syndrome: The PIONEER study protocol 503
A Randomized Trial of Acute Normovolemic Hemodilution in Cardiac Surgery 304
Mortality after surgery in Europe: A 7 day cohort study 194
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 180
A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients 177
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency 166
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 166
Continuous vs Intermittent Meropenem Administration in Critically Ill Patients With Sepsis: The MERCY Randomized Clinical Trial 156
Mastering the Sequential Organ Failure Assessment Score: Critical Choices of Score Statistic, Timing, Imputations, and Competing Risk Handling in Major Trials—A Systematic Review 155
Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumonia 154
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy 152
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 151
Effect of Remote Ischemic Preconditioning on Myocardial Injury in Noncardiac Surgery: the PRINCE Randomized Clinical Trial 142
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 138
Chest CT-derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy 138
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 137
Residual lung damage following ARDS in COVID-19 ICU survivors 137
High dose esomeprazole as an anti-inflammatory agent in sepsis: Protocol for a randomized controlled trial 133
Early noninvasive ventilation in general wards for acute respiratory failure: an international, multicentre, open-label, randomised trial 133
Amino acids and the kidney; friends or foes? 131
Sex-related mortality differences in young adult septic shock patients 131
Norepinephrine Salt Formulations and Risk of Therapeutic Error: Results of a National Survey 127
Intravenous amino acids for renal protection in patients receiving temporary mechanical circulatory support: a secondary subgroup analysis of the PROTECTION study 127
Anakinra for patients with COVID-19: an updated systematic review and meta-analysis 126
A Multinational Randomized Trial of Mega-Dose Esomeprazole As Anti-Inflammatory Agent in Sepsis 124
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 124
Angiotensin II infusion and markers of organ function in invasively ventilated COVID-19 patients 123
Continuous infusion versus intermittent administration of meropenem in critically ill patients (MERCY): A multicenter randomized double-blind trial. Rationale and design 119
Extracorporeal membrane oxygenation for prevention of barotrauma in patients with respiratory failure: A scoping review 117
Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy 114
Continuous infusion versus bolus injection of furosemide in pediatric patients after cardiac surgery: A meta-analysis of randomized studies 113
Hemodynamic Improvement in Acute Respiratory Distress Syndrome Patients After Venovenous Extracorporeal Membrane Oxygenation Implantation 108
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 108
Predictors and outcomes of delirium in the emergency department during the first wave of the COVID-19 pandemic in Milan 107
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 106
Two months quality of life of COVID-19 invasively ventilated survivors; an Italian single-center study 105
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 102
Could CPAP Devices Be Used to Ventilate Cardiac Arrest Patients? A Bench Study 100
Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute respiratory distress syndrome: a pooled analysis of four observational studies 100
Continuous infusion versus bolus injection of furosemide in critically ill patients. A systematic review and meta-analysis 98
Propofol and survival: a meta-analysis of randomized clinical trials 98
Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies 98
Predictors of Pneumothorax/Pneumomediastinum in Mechanically Ventilated COVID-19 Patients 97
Correction: Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial (Intensive Care Medicine, (2022), 48, 12, (1736-1750), 10.1007/s00134-022-06912-w) 94
Immunosuppressive strategies in invasively ventilated ARDS COVID-19 patients 94
Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic Shock 92
Noninvasive Ventilation of Patients with Acute Respiratory Distress Syndrome: Insights from the LUNG SAFE Study 92
AED training with a 3D-printed model and a smartphone app 90
Continuous infusion versus intermittent administration of meropenem in critically ill patients. A multicenter randomized double-blind trial 89
Dexamethasone in COVID-19: does one drug fit all? 89
Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trial 89
Is SARS-CoV-2-induced disease a decisive factor influencing testosterone in males? Findings from a case-control ex post facto study 88
Alteplase in COVID-19 severe hypoxemic respiratory failure: the TRISTARDS multicenter randomized trial 87
Home ventilators for invasive ventilation of patients with COVID-19 87
2012 pandemic flu 83
Clinical aspect of sepsis: an overview 83
Citrate anticoagulation to reduce mortality in patients needing continuous renal replacement therapy 82
Early progressive mobilization in intensive care unit without adjunctive personnel 82
Pulmonary Vascular Thrombosis in COVID-19 Pneumonia 82
Microvascular lung vessels obstructive thromboinflammatory syndrome in patients with COVID-19: Insights from lung intravascular optical coherence tomography 81
Activities of a medical emergency team twenty years after its introduction 81
Immunocompromised patients with acute respiratory distress syndrome: Secondary analysis of the LUNG SAFE database 80
Percutaneous tracheostomy in COVID-19 patients: a new apneic approach 79
Percutaneous tracheostomy, a systematic review. 77
PREDICTORS AND OUTCOMES OF DELIRIUM IN THE EMERGENCY DEPARTMENT IN COVID-19 PATIENTS 74
Non-invAsive VentIlation for early General wArd respiraTory failurE (NAVIGATE): A multicenter randomized controlled study. Protocol and statistical analysis plan 72
Human protein C concentrate in pediatric septic patients 70
The impact of non-blinding in critical care medicine trials 69
Single dilator vs. guide wire dilating forceps tracheostomy: a meta-analysis of randomised trials 68
Protective Hemodynamics: C.L.E.A.R.! 66
Nonsurgical Strategies to Reduce Mortality in Patients Undergoing Cardiac Surgery: An Updated Consensus Process 65
Dexamethasone in COVID-19: does one drug fits all? 65
Optimizing meropenem infusion: the importance of concentration and stability 63
Meropenem Administration in Critically Ill Patients With Sepsis-Reply 62
Outcome of cardiac surgery in patients with low preoperative ejection fraction 62
Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study 61
High doses proton pump inhibitors in sepsis: design of a randomized trial with in vitro experiments to search specific hallmarks in monocytes from septic patients and to characterize the mechanism of action of PPI 61
Long-term survival rate in patients with acute respiratory failure treated with noninvasive ventilation in ordinary wards 59
Death in hospital following ICU discharge: insights from the LUNG SAFE study 58
Vitamin D and outcomes in adult critically ill patients. A systematic review and meta-analysis of randomized trials 58
Spinal analgesia in cardiac surgery: a meta-analysis of randomized controlled trials 57
Non-invasive ventilation after cardiac surgery outside the Intensive Care Unit 57
Human protein C concentrates in adult septic patients 56
Decreasing mortality with drotrecogin alfa in high risk septic patients A meta-analysis of randomized trials in adult patients with multiple organ failure and mortality >40% 56
Interventions affecting mortality in critically ill and perioperative patients: A systematic review of contemporary trials 56
Mechanical ventilation in patients with cardiogenic pulmonary edema: a sub-analysis of the LUNG SAFE study 55
Nerve Compression Injuries After Prolonged Prone Position Ventilation in Patients With SARS-CoV-2: A Case Series 55
Decision making in the democracy-based medicine era: The consensus conference process 54
Safety and efficacy of percutaneous tracheostomy techniques in critically ill patients: a comparative meta-analysis of randomized trials 53
Observed versus predicted hospital mortality in general wards patients assisted by a medical emergency team 52
Management of critically ill patients with coviD-19: suggestions and instructions from the coordination of intensive care units of lombardy 52
Towards zero perioperative mortality. 50
Levosimendan: new indications and evidence for reduction in perioperative mortality? 49
Monitoring non-invasive ventilation outside the intensive care unit 49
Identifying associations between diabetes and acute respiratory distress syndrome in patients with acute hypoxemic respiratory failure: an analysis of the LUNG SAFE database 48
Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome: Insights from the LUNG SAFE study 47
Preventing deaths related to percutaneous tracheostomy: safety is never too much! 47
The authors reply 45
The Brachiocephalic Vein as a Safe and Viable Alternative to Internal Jugular Vein for Central Venous Cannulation 45
Noninvasive Ventilation After Thoracoabdominal Aortic Surgery: A Pilot Randomized Controlled Trial 45
Totale 9.981
Categoria #
all - tutte 44.386
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.386


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 0 0 0 0 0 0 0 9 1
2021/2022117 0 0 1 30 8 11 13 24 6 7 11 6
2022/2023410 142 88 26 5 15 46 16 36 14 2 8 12
2023/2024686 21 29 97 41 62 137 39 47 9 19 50 135
2024/20252.016 175 41 35 117 90 154 281 218 356 195 132 222
2025/20266.963 552 626 823 771 608 254 633 585 1.786 325 0 0
Totale 10.305